Salvatore DʼAgate

Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH

Salvatore DʼAgate, Timothy H. Wilson, Burkay Adalig et al. · World Journal of Urology · 2019 · 23 citations · Full text

Medicine, Pharmacotherapy, Urology +14

Impact of early vs. delayed initiation of dutasteride/tamsulosin combination therapy on the risk of acute urinary retention or BPH-related surgery in LUTS/BPH patients with moderate-to-severe symptoms at risk of disease progression

Salvatore DʼAgate, Chandrashekhar Chavan, Michael J. Manyak et al. · World Journal of Urology · 2020 · 19 citations · Full text

Medicine, Pharmacotherapy, Urology +13

Dose Rationale for Amoxicillin in Neonatal Sepsis When Referral Is Not Possible

Salvatore DʼAgate, Flora T. Musuamba, Oscar Della Pasqua · Frontiers in Pharmacology · 2020 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Development and validation of a quantification method for cucurbitacins E and I in rat plasma: Application to population pharmacokinetic studies

Giovana Maria Lanchoti Fiori, Salvatore DʼAgate, Adriana Rocha et al. · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 11 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +7

Model-Informed Repurposing of Medicines for SARS-CoV-2: Extrapolation of Antiviral Activity and Dose Rationale for Paediatric Patients

Federico Romano, Salvatore DʼAgate, Oscar Della Pasqua · Pharmaceutics · 2021 · 11 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17